[8-K] MetLife, Inc. Reports Material Event

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

MetLife has disclosed preliminary variable investment income estimates for Q2 2025 in an 8-K filing. The company projects variable investment income to be between $175 million - $225 million (pre-tax) for the quarter ended June 30, 2025. This includes income from private equity, real estate and other funds, and prepayment fees.

Key points from the disclosure:

Full Q2 2025 earnings release and financial supplement scheduled for August 6, 2025
Preliminary figures are unaudited and subject to change pending completion of financial closing procedures
Management emphasizes these results are estimates based on currently available information

The filing was signed by Toby S. Brown, Executive Vice President, Global Head of Reinsurance and Interim Chief Accounting Officer. The company includes standard cautionary language regarding forward-looking statements and notes this disclosure is being furnished under Regulation FD requirements.

Insights

MetLife discloses unaudited Q2-25 variable investment income of $175-$225 m pre-tax; visibility improves, but lacking prior-period context keeps impact muted.

Scope of the disclosure. Item 7.01 furnishes an estimated range for variable investment income 鈥� private-equity, real-estate and prepayment-fee returns 鈥� ahead of the full earnings release set for 6 August 2025.

Materiality. The filing isolates one income line rather than full results. Management labels it 鈥減reliminary鈥� and 鈥渦naudited,鈥� warning actual figures could differ materially. Because no comparative period data or company guidance accompanies the range, the magnitude of deviation鈥攑ositive or negative鈥攃annot be assessed from this document alone.

Usefulness. Early disclosure reduces information asymmetry around a historically volatile revenue stream. For stakeholders who model MetLife鈥檚 quarterly earnings, the range allows tighter, though still provisional, estimates of pretax income. However, the disclaimer that the information is not 鈥渇iled鈥� under Section 18 limits legal reliance.

Risk considerations. The forward-looking caveats remind readers that private-equity and real-estate valuations are sensitive to market conditions. A final figure outside the stated range could trigger perception of forecasting inaccuracy. The company also directs readers to previously stated 鈥淩isk Factors,鈥� highlighting potential volatility.

Bottom line. The 8-K offers incremental transparency but, absent comparative figures, does not unequivocally signal strength or weakness. Overall financial and strategic implications remain pending the full Q2 release.

06/23/2025 - 04:08 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 23, 2025

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-15787

13-4075851

(Commission File Number)

(IRS Employer Identification No.)

200 Park Avenue,

New York,

10166-0188

(Address of Principal Executive Offices)

(Zip Code)

(212) 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01	MET	New York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01	MET PRA	New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E	MET PRE	New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F	MET PRF	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose preliminary information regarding variable investment income prior to the availability of the Company’s quarterly earnings release and quarterly financial supplement for the quarter ended June 30, 2025, scheduled for release on August 6, 2025.

For the quarter ended June 30, 2025, the Company estimates that its variable investment income will be approximately $175 million - $225 million (pre-tax). Variable investment income includes private equity, real estate and other funds and prepayment fees.

The preliminary financial information presented above for the quarter ended June 30, 2025, is estimated and unaudited and has been prepared in good faith on a basis consistent with prior periods based on information available to management as of the date hereof; however, we have not completed our financial closing procedures for the quarter ended June 30, 2025, and our actual results could be materially different from these preliminary financial results. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information regarding financial or operating data not provided. These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP. In addition, these preliminary financial results are not necessarily indicative of the results to be achieved in any future period.

The forward-looking statements in this disclosure, which use terms such as “estimates” and “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife, Inc.’s results could differ materially from those it expresses or implies in forward-looking statements. MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved.

As provided in General Instruction B.2 of Form 8-K, the information provided pursuant to this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

METLIFE, INC.

By:

/s/ Toby S. Brown

Name:

Toby S. Brown

Title:

Executive Vice President,
Global Head of Reinsurance and
Interim Chief Accounting Officer

Date: June 23, 2025

Source:

AG真人官方